Volinanserin

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameVolinanserin
Drug Alias Name氟利色林volinanserinumvolinanserina沃立色林MDL-100907 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsDepressive DisorderSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[29] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiNational Institute Of Mental Health (Nimh)
Active IndicationsN/A
Inactive IndicationsDepressive DisorderSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksWikipedia